Susquehanna International Group, LLP Lexaria Bioscience Corp. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.69 - $2.69 $35,897 - $139,949
-52,026 Reduced 77.13%
15,426 $11,000
Q1 2023

May 16, 2023
BUY
$2.47 - $3.47 $3,262 - $4,583
1,321 Added 2.0%
67,452 $183,000
Q4 2022

Feb 14, 2023
BUY
$1.95 - $2.98 $50,723 - $77,515
26,012 Added 64.84%
66,131 $162,000
Q3 2022

Nov 14, 2022
BUY
$0.74 - $3.28 $29,688 - $131,590
40,119 New
40,119 $98,000

Others Institutions Holding LEXX

# of Institutions
27
Shares Held
1.06M
Call Options Held
0
Put Options Held
0
View Full List

About Lexaria Bioscience Corp.

LEXX Quotes by TradingView
  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $13.7M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email